Literature DB >> 26419801

Translating the effects of mTOR on secretory senescence.

Kosuke Tomimatsu1, Masashi Narita1.   

Abstract

Cellular senescence is often accompanied by the production of secreted proteins that mediate the diverse effects of senescence on the tissue microenvironment. The mammalian target of rapamycin (mTOR), a master regulator of protein synthesis, is now shown to control the senescence-associated secretory phenotype by modulating gene transcription and mRNA translation and stabilization.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26419801     DOI: 10.1038/ncb3244

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  15 in total

1.  Spatial coupling of mTOR and autophagy augments secretory phenotypes.

Authors:  Masako Narita; Andrew R J Young; Satoko Arakawa; Shamith A Samarajiwa; Takayuki Nakashima; Sei Yoshida; Sungki Hong; Lorraine S Berry; Stefanie Reichelt; Manuela Ferreira; Simon Tavaré; Ken Inoki; Shigeomi Shimizu; Masashi Narita
Journal:  Science       Date:  2011-04-21       Impact factor: 47.728

2.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

3.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.

Authors:  Remi-Martin Laberge; Yu Sun; Arturo V Orjalo; Christopher K Patil; Adam Freund; Lili Zhou; Samuel C Curran; Albert R Davalos; Kathleen A Wilson-Edell; Su Liu; Chandani Limbad; Marco Demaria; Patrick Li; Gene B Hubbard; Yuji Ikeno; Martin Javors; Pierre-Yves Desprez; Christopher C Benz; Pankaj Kapahi; Peter S Nelson; Judith Campisi
Journal:  Nat Cell Biol       Date:  2015-07-06       Impact factor: 28.824

4.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

Review 5.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

6.  Rapamycin decelerates cellular senescence.

Authors:  Zoya N Demidenko; Svetlana G Zubova; Elena I Bukreeva; Valery A Pospelov; Tatiana V Pospelova; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

7.  Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.

Authors:  Arturo V Orjalo; Dipa Bhaumik; Bridget K Gengler; Gary K Scott; Judith Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

8.  The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2.

Authors:  Sushmit Maitra; Chu-Fang Chou; Christian A Luber; Kyung-Yeol Lee; Matthias Mann; Ching-Yi Chen
Journal:  RNA       Date:  2008-03-06       Impact factor: 4.942

9.  Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.

Authors:  Jan R Dörr; Yong Yu; Maja Milanovic; Gregor Beuster; Christin Zasada; J Henry M Däbritz; Jan Lisec; Dido Lenze; Anne Gerhardt; Katharina Schleicher; Susanne Kratzat; Bettina Purfürst; Stefan Walenta; Wolfgang Mueller-Klieser; Markus Gräler; Michael Hummel; Ulrich Keller; Andreas K Buck; Bernd Dörken; Lothar Willmitzer; Maurice Reimann; Stefan Kempa; Soyoung Lee; Clemens A Schmitt
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  The translational landscape of mTOR signalling steers cancer initiation and metastasis.

Authors:  Andrew C Hsieh; Yi Liu; Merritt P Edlind; Nicholas T Ingolia; Matthew R Janes; Annie Sher; Evan Y Shi; Craig R Stumpf; Carly Christensen; Michael J Bonham; Shunyou Wang; Pingda Ren; Michael Martin; Katti Jessen; Morris E Feldman; Jonathan S Weissman; Kevan M Shokat; Christian Rommel; Davide Ruggero
Journal:  Nature       Date:  2012-02-22       Impact factor: 69.504

View more
  12 in total

Review 1.  Translational Control during Cellular Senescence.

Authors:  Matthew J Payea; Carlos Anerillas; Ravi Tharakan; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

Review 2.  Regulation of senescence traits by MAPKs.

Authors:  Carlos Anerillas; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Geroscience       Date:  2020-04-16       Impact factor: 7.713

3.  Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide.

Authors:  Si-Yang Wang; Wen-Juan Wang; Jie-Qiong Liu; Yu-Huan Song; Ping Li; Xue-Feng Sun; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Cell Cycle       Date:  2019-06-05       Impact factor: 4.534

4.  Recent advances in radiobiology with respect to pleiotropic aspects of tissue reaction.

Authors:  Keiji Suzuki; Aidana Amrenova; Norisato Mitsutake
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 5.  Senescence and tumor suppression.

Authors:  Philip Hinds; Jodie Pietruska
Journal:  F1000Res       Date:  2017-12-11

6.  A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle.

Authors:  Haynes Shek Hei Yuan; Sachin Katyal; Judy E Anderson
Journal:  Oncotarget       Date:  2018-04-27

Review 7.  Short-term gain, long-term pain: the senescence life cycle and cancer.

Authors:  Adelyne Sue Li Chan; Masashi Narita
Journal:  Genes Dev       Date:  2019-02-01       Impact factor: 11.361

8.  A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.

Authors:  Eric H Bent; Luke A Gilbert; Michael T Hemann
Journal:  Genes Dev       Date:  2016-08-26       Impact factor: 11.361

9.  mTOR signaling orchestrates the expression of cytoprotective factors during cellular senescence.

Authors:  Reut Yosef; Valery Krizhanovsky
Journal:  Oncotarget       Date:  2016-08-02

10.  Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.

Authors:  Fei Chen; Qilai Long; Da Fu; Dexiang Zhu; Yan Ji; Liu Han; Boyi Zhang; Qixia Xu; Bingjie Liu; Yan Li; Shanshan Wu; Chen Yang; Min Qian; Jianmin Xu; Suling Liu; Liu Cao; Y Eugene Chin; Eric W-F Lam; Jean-Philippe Coppé; Yu Sun
Journal:  Nat Commun       Date:  2018-10-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.